Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France.
Univ. Bordeaux, ISPED, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France.
PLoS One. 2020 Oct 22;15(10):e0240906. doi: 10.1371/journal.pone.0240906. eCollection 2020.
Although physical function decline is common with aging, the burden of this impairment remains underestimated in patients living with HIV (PLHIV), particularly in the older people receiving antiretroviral treatment (ART) and living in sub-Saharan Africa (SSA). PLHIV aged ≥50 years old and on ART since ≥6 months were included (N = 333) from three clinics (two in Côte d'Ivoire, one in Senegal) participating in the International epidemiological Databases to Evaluate AIDS (IeDEA) West Africa collaboration. Physical function was measured using the Short Physical Performance Battery (SPPB), the unipodal balance test and self-reported questionnaires. Grip strength was also assessed. Logistic regression was used to identify the factors associated with SPPB performance specifically. Median age was 57 (54-61) years, 57.7% were female and 82.7% had an undetectable viral load. The mean SPPB score was 10.2 ±1.8. Almost 30% had low SPPB performance with the 5-sit-to-stand test being the most altered subtest (64%). PLHIV with low SPPB performance also had significantly low performance on the unipodal balance test (54.2%, p = 0.001) and low mean grip strength (but only in men (p = 0.005)). They also showed some difficulties in daily life activities (climbing stairs, walking one block, both p<0.0001). Age ≥60 years (adjusted OR (aOR) = 3.4; CI95% = 1.9-5.9,), being a female (aOR = 2.1; CI95% = 1.1-4.1), having an abdominal obesity (aOR = 2.1; CI95% = 1.2-4.0), a longer duration of HIV infection (aOR = 2.9; CI95% = 1.5-5.7), old Nucleoside reverse transcriptase inhibitors (NRTIs) (i.e., AZT: zidovudine, ddI: didanosine, DDC: zalcitabine, D4T: stavudine) in current ART (aOR = 2.0 CI95% = 1.1-3.7) were associated with low SPPB performance. As in western countries, physical function limitation is now part of the burden of HIV disease complications of older PLHIV living in West Africa, putting this population at risk for disability. How to screen those impairments and integrate their management in the standards of care should be investigated, and specific research on developing adapted daily physical activity program might be conducted.
虽然身体功能下降在老年人中很常见,但在感染艾滋病毒的患者(PLHIV)中,这种功能障碍的负担仍然被低估,尤其是在接受抗逆转录病毒治疗(ART)并居住在撒哈拉以南非洲(SSA)的老年人中。来自三个参与国际艾滋病流行病学数据库评估合作(IeDEA)西非合作的诊所(两个在科特迪瓦,一个在塞内加尔)的年龄≥50 岁且接受 ART≥6 个月的年龄≥50 岁的 PLHIV(N=333)被纳入研究。使用短体物理表现电池(SPPB)、单足平衡测试和自我报告问卷评估身体功能。还评估了握力。使用逻辑回归来确定与 SPPB 表现相关的因素。中位年龄为 57(54-61)岁,57.7%为女性,82.7%的人病毒载量无法检测到。SPPB 评分的平均值为 10.2±1.8。几乎 30%的人 SPPB 表现不佳,其中 5 次坐立测试是改变最大的亚测试(64%)。SPPB 表现不佳的 PLHIV 也在单足平衡测试中表现出明显较低的表现(54.2%,p=0.001)和较低的平均握力(但仅在男性中(p=0.005))。他们在日常生活活动中也遇到了一些困难(爬楼梯、走一个街区,均 p<0.0001)。年龄≥60 岁(调整后的 OR(aOR)=3.4;95%CI=1.9-5.9)、女性(aOR=2.1;95%CI=1.1-4.1)、腹部肥胖(aOR=2.1;95%CI=1.2-4.0)、艾滋病毒感染时间较长(aOR=2.9;95%CI=1.5-5.7)、当前 ART 中使用旧的核苷逆转录酶抑制剂(NRTIs)(即 AZT:齐多夫定、ddI:双脱氧肌苷、DDC:扎西他滨、D4T:司他夫定)(aOR=2.0,95%CI=1.1-3.7)与 SPPB 表现不佳相关。与西方国家一样,身体功能障碍现在是居住在西非的老年 PLHIV 艾滋病毒疾病并发症负担的一部分,使该人群面临残疾风险。如何筛查这些损伤并将其管理纳入护理标准应进行调查,可能需要对开发适应日常身体活动的方案进行专门研究。